鐔麗霞 郭清 張少靜 薛穎 王瑜
·論著·
動(dòng)態(tài)監(jiān)測(cè)血清CA125及孕酮在預(yù)測(cè)早期異位妊娠結(jié)局的意義
鐔麗霞 郭清 張少靜 薛穎 王瑜
目的動(dòng)態(tài)監(jiān)測(cè)早孕期血清CA125及孕酮水平,探討其在預(yù)測(cè)早期異位妊娠結(jié)局的價(jià)值。方法選取2011年3月至2013年2月于該院門診正常妊娠及疑為異位妊娠或先兆流產(chǎn)而入院的80例患者作為研究對(duì)象,按妊娠結(jié)局分為正常妊娠分娩組20例,先兆流產(chǎn)保胎成功分娩組20例,先兆流產(chǎn)發(fā)展為稽留流產(chǎn)組20例,異位妊娠組20例,對(duì)所有病例進(jìn)行血清CA125及孕酮?jiǎng)討B(tài)監(jiān)測(cè),并進(jìn)行統(tǒng)計(jì)學(xué)分析與處理。結(jié)果先兆流產(chǎn)保胎成功分娩組孕酮水平高于稽留流產(chǎn)組,明顯高于異位妊娠組,均有明顯統(tǒng)計(jì)學(xué)意義(P<0.05)。早期妊娠階段,正常妊娠分娩組、先兆流產(chǎn)保胎成功分娩組、先兆流產(chǎn)保胎失敗組,孕酮水平差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05)。早期妊娠階段,4組血清CA125平均水平均高于正常值且呈緩慢上升趨勢(shì),正常妊娠分娩組、先兆流產(chǎn)保胎成功分娩組呈緩慢上升趨勢(shì),兩者無(wú)明顯統(tǒng)計(jì)學(xué)意義(P>0.05),而先兆流產(chǎn)發(fā)展為稽留流產(chǎn)組及異位妊娠組的CA125水平高于前2組(P<0.05),但2組無(wú)明顯統(tǒng)計(jì)學(xué)意義(P>0.05),但分別與正常妊娠分娩組及及保胎成功分娩組相比,均有統(tǒng)計(jì)學(xué)意義(P<0.05)。結(jié)論動(dòng)態(tài)監(jiān)測(cè)血清孕酮聯(lián)合CA125值,能夠更準(zhǔn)確的預(yù)測(cè)早期異位妊娠結(jié)局。
CA125 孕酮;早期異位妊娠;妊娠結(jié)局
孕激素是維持正常妊娠的必要條件,在妊娠的初期,孕酮的主要來(lái)源是妊娠黃體,孕酮水平不足時(shí),胚胎發(fā)育受阻,孕酮水平的高低對(duì)早期妊娠的預(yù)后有重要意義[1],但在早孕期間,各孕周間孕酮水平比較差異無(wú)統(tǒng)計(jì)學(xué)意義。孕婦早期妊娠中最常見(jiàn)的三種異常情況分別是先兆流產(chǎn)、稽留流產(chǎn)及異位妊娠,其中,早期流產(chǎn)占妊娠總數(shù)80%以上,但早期先兆流產(chǎn)原因復(fù)雜多樣,可能與胚胎、母體、免疫功能異常及環(huán)境等多種因素有關(guān),臨床上目前普遍采用動(dòng)態(tài)監(jiān)測(cè)血人絨毛膜促性腺激素(β-HCG)及B超來(lái)判斷妊娠結(jié)局[2],據(jù)文獻(xiàn)報(bào)道,異位妊娠的超聲診斷準(zhǔn)確率高達(dá)90.38%[3],但在妊娠早期,β-HCG和B超診斷缺乏特異性和敏感性。國(guó)內(nèi)外研究表明,血清癌相關(guān)糖抗原125(CA125)水平有助于判斷先兆流產(chǎn)結(jié)局[4],CA125是一種高分子糖蛋白,大量存在于胎兒絨毛膜、羊水和母體蛻膜中,是來(lái)源于體腔上皮、生殖道黏膜及卵巢上皮細(xì)胞表面的一種衍生腫瘤抗原標(biāo)志物,在妊娠早期明顯升高,妊娠中期后逐漸下降,分娩后又很快升高,如蛻膜細(xì)胞破壞越多或滋養(yǎng)細(xì)胞與蛻膜分離越多,CA125就會(huì)更高。因此,血CA125水平對(duì)早期妊娠、流產(chǎn)、異位妊娠的治療方法的選擇有一定的臨床指導(dǎo)意義[5]。本文通過(guò)動(dòng)態(tài)監(jiān)測(cè)對(duì)比正常妊娠、先兆流產(chǎn)、稽留流產(chǎn)及異位妊娠患者的血清孕酮及CA125水平,以達(dá)到早期診斷及合理治治目的。
1.1 一般資料 選取2011年3月至2013年2月于該院門診正常妊娠患者或有停經(jīng)史、無(wú)明顯腹痛及陰道流血,但疑診為先兆流產(chǎn)或異位妊娠而進(jìn)行隨診的患者共80例,按妊娠結(jié)局分為正常妊娠至分娩組20例,先兆流產(chǎn)保胎成功組20例,先兆流產(chǎn)發(fā)展為稽留流產(chǎn)組20例,異位妊娠組20例。各組病例均排除合并有子宮內(nèi)膜異位癥或盆腔炎性疾病、卵巢腫瘤病史及通過(guò)輔助生育受孕者。先兆流產(chǎn)保安胎成功組20例均為住院后診斷宮內(nèi)妊娠,經(jīng)安胎治療后,無(wú)陰道流血,復(fù)查B超提示“宮內(nèi)胚胎存活”的病例,年齡(21.3±7.1)歲,停經(jīng)天數(shù)(34±6)d?;袅鳟a(chǎn)組20例經(jīng)常規(guī)安胎治療后陰道流血繼續(xù),B超提示“胚胎停育”的病例,均進(jìn)行清宮術(shù),送病理檢查均證實(shí)有絨毛組織;年齡(23±4)歲,停經(jīng)天數(shù)(35±5)d。異位妊娠組20例,經(jīng)B超檢查、診斷性刮宮或腹腔鏡探查及術(shù)后病理檢查等確診,年齡(23±5)歲,停經(jīng)(37±2)d。4組病例年齡和停經(jīng)天數(shù)差異均無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05),具有可比性。
1.2 方法 所有病例空腹抽取靜脈血2 ml分離血清,動(dòng)態(tài)監(jiān)測(cè)孕酮和CA125水平及行婦科腔內(nèi)彩超監(jiān)測(cè)宮內(nèi)外情況變化。儀器采用羅氏電生化發(fā)光全自動(dòng)免疫分析儀ELECSYS2010,檢測(cè)試劑由羅氏公司提供。經(jīng)確診為宮內(nèi)妊娠先兆流產(chǎn)癥狀的患者給予保胎者常規(guī)每日肌內(nèi)注射1次HCG(1 000~2 000 U)或口服地屈孕酮進(jìn)行保胎治療,每周測(cè)定1次血清孕酮及CA125值,直至流產(chǎn)或保胎成功出院,所有病例均未口服或肌內(nèi)注射黃體酮。確定為異位妊娠者根據(jù)治療指征分別進(jìn)行患側(cè)輸卵管開(kāi)窗取胚手術(shù)治療14例及患側(cè)輸卵管切除手術(shù)治療6例,術(shù)后病理證實(shí)為異位妊娠。
2.1 4組血清孕酮的比較 正常妊娠組第1天及第7天孕酮水平與先兆流產(chǎn)安胎成功組,孕酮水平均符合正常水平(P>0.05);先兆流產(chǎn)保胎成功組與發(fā)展為稽留流產(chǎn)組比較,前者血清孕酮值,高于后者(P<0.05),發(fā)展為稽留流產(chǎn)組與異位妊娠組相比較,前者血清孕酮值,高于后者(P<0.05)。見(jiàn)表1。
表1 4組血清孕酮的平均水平
表1 4組血清孕酮的平均水平
組別孕酮(第1天)孕酮(第7天)正常妊娠組74±2178±18先兆流產(chǎn)保胎成功組 75±16* 74±17*先兆流產(chǎn)發(fā)展為稽留流產(chǎn)組67±1945±13異位妊娠組 66±14* 62±12*
注:與先兆流產(chǎn)發(fā)展為稽留流產(chǎn)組,*P<0.05
2.2 4組血清孕酮的比較 4組患者在第一次隨診時(shí)均無(wú)明顯腹痛及陰道出血,行血清CA125水平檢測(cè)無(wú)明顯區(qū)別,動(dòng)態(tài)監(jiān)測(cè),第7天,正常妊娠組及保胎成功組均有輕度上升,2組差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05),而先兆流產(chǎn)組及異位妊娠組血清CA125水平上升明顯,2組差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05),但2組與正常妊娠組比較差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。見(jiàn)表2。
表2 4組血清CA125平均水平比較
表2 4組血清CA125平均水平比較
組別第1天第7天正常妊娠組35±1240±14 先兆流產(chǎn)保胎成功組34±1441±12*先兆流產(chǎn)發(fā)展為稽留流產(chǎn)組36±1351±13*異位妊娠組34±1252±12*
注:與正常妊娠組比較,*P<0.05
在妊娠期間,導(dǎo)致早期流產(chǎn)發(fā)生的常見(jiàn)原因有遺傳缺陷、黃體功能不全、胎盤內(nèi)分泌功能不全等,對(duì)有先兆流產(chǎn)情況給予保胎治療的同時(shí),應(yīng)盡早對(duì)宮內(nèi)發(fā)育的狀態(tài)進(jìn)行評(píng)估從而進(jìn)行早期診斷,以避免不必要的保胎[5]。
傳統(tǒng)早期診斷妊娠及結(jié)局常以動(dòng)態(tài)監(jiān)測(cè)血β-HCG輔以腔內(nèi)超聲診斷來(lái)進(jìn)行判斷,但在妊娠早期β-HCG和超聲診斷均缺乏特異性和敏感性。血β-HCG值在早孕時(shí)個(gè)體差異很大,可比性相對(duì)較差,需連續(xù)動(dòng)態(tài)測(cè)定,而孕酮在孕5~10周時(shí)相對(duì)穩(wěn)定[6],且數(shù)值水平與孕齡不相關(guān),正常的宮內(nèi)妊娠血清孕酮水平在25 ng/ml及以上,如低于5 ng/ml則提示妊娠不良,但早期妊娠階段,患者孕酮水平多在10~20 ng/ml[7],因此,如單純依靠血清孕酮水平,仍無(wú)法鑒別更準(zhǔn)確預(yù)測(cè)妊娠結(jié)局。在妊娠早期階段,滋養(yǎng)細(xì)胞的變性壞死可導(dǎo)致外周血CA125升高,并且可直接或間接影響孕酮的分泌,不良妊娠結(jié)局,異位妊娠,尤其是輸卵管妊娠,輸卵管黏膜被破壞,CA125進(jìn)入母體外周血循環(huán),導(dǎo)致血清CA125水平較正常妊娠有明顯升高[8]。
本文通過(guò)觀察正常妊娠、先兆流產(chǎn)安胎成功組、稽留流產(chǎn)組、異位妊娠組,監(jiān)測(cè)各組病例血清孕酮及CA125值,結(jié)果提示,在早期妊娠過(guò)程中,正常妊娠及先兆流產(chǎn)安胎成功組的孕酮平均值高于稽留流產(chǎn)組、異位妊娠組,有明顯統(tǒng)計(jì)學(xué)意義。在妊娠早期階段,正常妊娠、先兆流產(chǎn)安胎成功組、稽留流產(chǎn)組、異位妊娠組的血CA125均有升高,4組CA125平均水平呈逐漸上升趨勢(shì),但稽留流產(chǎn)組、異位妊娠組均存在滋養(yǎng)細(xì)胞的變性壞死,蛻膜細(xì)胞破壞多,滋養(yǎng)細(xì)胞的變性壞死導(dǎo)致外周血CA125增加更加明顯,因此血CA125值上升明顯。因此,聯(lián)合檢測(cè)血清CA125及孕酮對(duì)診斷稽留流產(chǎn)及異位妊娠有重要意義,同時(shí)對(duì)可盡早發(fā)現(xiàn)內(nèi)分泌功能不足而造成的先兆流產(chǎn),對(duì)治療有指導(dǎo)作用。因此,對(duì)早期異位妊娠患者進(jìn)行血清CA125及孕酮兩者聯(lián)合監(jiān)測(cè),比單項(xiàng)測(cè)定準(zhǔn)確率更高,更有優(yōu)越性,對(duì)判斷預(yù)后及盡早指導(dǎo)治療都有重要的臨床應(yīng)用價(jià)值。
1 Abbott L.Ectopicpregnancy:symptoms,diagnosisand management.Nurs Times,2004,100:32-37.
2 Fiegler P,Katz M,Kaminski K,et al.Clinical valueofa single serum CA125 level inwomenwith symptomof imminent abortion during the first trimester of prenancy.J Reprod Med,2003,48:982-988.
3 孫麗麗,黃翠青.經(jīng)陰道超聲檢查對(duì)異位妊娠的定位診斷價(jià)值.軍醫(yī)進(jìn)修學(xué)院學(xué)報(bào),2012,33:1278-1280.
4 Bast RC,Feeney M,Zarus H,et al.Reactivity ofmonoclonal antibody with human ovarian careinom.Clin Invest,1981,68:1331-1337.
5 周秀琴,童順桃,雷慧中.癌相關(guān)糖抗原125在女性生殖系統(tǒng)腫瘤診斷中的應(yīng)用.中國(guó)誤診學(xué)雜志,2002,2:174-176.
6 黃雙美,邱萬(wàn)臣.異位妊娠早期血清β-HCG和孕酮聯(lián)合測(cè)定的臨床意義.河北醫(yī)藥,2010,32:1639.
7 Speroff L,Glass RH.Ectopic pregnancy.In Spiroff L,ed.Clinical Gynecologic Endocrinology and Infertility.6th ED.Philadelphia:Lippincott Williams or Williams,2010.1149-1167.
8 Predanic M.Differentiatin tubal abortion from viable ectopic pregnancywith serum CA125 and beta-human chorionic gornadotrotropindeterminations.Fertil Steril,2000,73:522-525.
The significance of dynamic surveillance of serum levels of progesterone and CA125 in predicting the outcome of early ectopic pregnancy
TANLixia,GUOQing,ZHANGShaojing,etal.DepartmentofObstetricsandGynecology,TheFirstHospitalofShijiazhuangCity,Shijiazhuang050011,China
ObjectiveTo detect dynamically the serum levels of progesterone and CA125 in order to explore their significance in predicting the outcome of early ectopic pregnancy.MethodsEighty pregnant women who were suspected for threatened abortion or ectopic pregnancy between 2011 March to 2013 February during clinic service were enrolled in the study.These women were divided into four groups according to pregnancy outcome;normal pregnancy group (n=20),threatened abortion group (n=20),missed abortion group (n=20) and ectopic pregnancy group (n=20).The serum levels of progesterone and CA125 were detect dynamically in all the subjects,and the results were treated and analyzed statistically.ResultsThe serum levels of progesterone in threatened abortion group were significantly higher than those of missed abortion group (P<0.05).During early pregnancy there were no significant differences in serum levels of progesterone among normal pregnancy group,threatened abortion group and missed abortion group (P>0.05),however,the serm levels of CA125 were obviously higher than normal levels in the 4 groups,with slow increase tendency,but there were no significant differences between normal pregnancy group and threatened abortion group (P>0.05).The serum levels of CA125 in missed abortion group and ectopic pregnancy group were significantly higher than those in normal pregnancy group and threatened abortion group (P<0.05),however,there were no significant differences between missed abortion group and ectopic pregnancy group (P>0.05).However the CA125 levels in threatened abortion group and ectopic pregnancy group were significantly higher than those of the other two groups (P<0.05).ConclusionThe combined dynamic detection of serum levels of progesterone and CA125 can predict the outcome of early ectopic pregnancy more accurately.
CA125;progesterone;early ectopic pregnancy;pregnancy outcome
10.3969/j.issn.1002-7386.2014.07.007
項(xiàng)目來(lái)源:河北省醫(yī)學(xué)科學(xué)研究與發(fā)展計(jì)劃項(xiàng)目(編號(hào):06146363)
050011 河北省石家莊市第一醫(yī)院婦產(chǎn)科
郭清,050011 河北省石家莊市第一醫(yī)院婦產(chǎn)科; E-mail:yfguoqing@163.com
R 714.22
A
1002-7386(2014)07-0984-03
2013-10-11)